MCS.NYSEMarcus CORP

Form 4: Marcus Corp Director Gershowitz Reports Stock Transactions

Sentiment:

SEC Form 4


Director Diane M. Gershowitz reports changes in beneficial ownership of Marcus Corporation stock, including conversions, disposals, and holdings through various entities.

Summary

  • On March 5, 2024, Diane M. Gershowitz, a director of Marcus Corporation, reported transactions involving the company's common stock and Class B common stock.
  • These transactions included the conversion of 31,770 shares of Class B common stock into common stock, the disposal of 33,328 shares of common stock, and holdings through DG-LDJ Holdings, LLC.
  • Gershowitz also reported holdings of stock options with various exercise prices and expiration dates, as well as holdings of Class B common stock through trusts.
  • Following the reported transactions, Gershowitz directly owns 34,929 shares of common stock and indirectly owns 200,617.223 shares through DG-LDJ Holdings, LLC.
  • She also indirectly owns 1,943,196 shares of common stock through DG-LDJ Holdings, LLC related to Class B Common Stock, and holds Class B Common Stock through trusts.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The transactions may be of interest to shareholders as they provide insight into the actions of a company insider.

Key Dates

DateDescription
05/29/2014Date of stock option grant with an exercise price of $16.84 and an expiration date of 05/29/2024
05/28/2015Date of stock option grant with an exercise price of $19.65 and an expiration date of 05/28/2025
12/29/2015Date of stock option grant with an exercise price of $18.97 and an expiration date of 12/29/2025
12/29/2016Date of stock option grant with an exercise price of $31.55 and an expiration date of 12/29/2026
12/28/2017Date of stock option grant with an exercise price of $27.2 and an expiration date of 12/28/2027
12/27/2018Date of stock option grant with an exercise price of $38.51 and an expiration date of 12/27/2028
12/26/2019Date of stock option grant with an exercise price of $32.6 and an expiration date of 12/26/2029
12/30/2021Date of stock option grant with an exercise price of $17.95 and an expiration date of 12/30/2031
12/29/2022Date of stock option grant with an exercise price of $14.25 and an expiration date of 12/29/2032
12/28/2023Date of stock option grant with an exercise price of $14.69 and an expiration date of 12/28/2033
03/05/2024Date of the reported transactions, including conversion and disposal of shares.
03/07/2024Date of signature of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.